Type: Landing
… Data Portability Right to Withdraw ConsentRight to Lodge a Complaint with a Data Protection Supervisory AuthorityYou … be aware that data entered onto our European Union Websites may be processed outside the EU only under those …
Type: Press Release
… Door to Balloon "DTB" for the angioplasty balloon The recommended treatment in guidelines for STEMI is … their first heart attack 36% of men and 47% of women will die due to heart failure1 It is estimated that the number of … to initiate in the first half of calendar 2017 and be completed within 18 months The primary endpoint of the study …
Type: Press Release
… DANVERS Mass Jan 26 2015 (GLOBE NEWSWIRE) -- In response to the state of … now be held on Wednesday January 28 CONFERENCE CALL The Company will host a conference call to discuss the results … live please tune into the webcast via http//investorabiomedcom or dial (855) 212-2361 the international number is (678) …
Type: Press Release
… revenue of approximately $154 million an increase of 34% compared to revenue of $1147 million for the same period of … also be available on the investor section of the companys website at wwwabiomedcom A replay of the webcast will be …
Type: Press Release
… and operational highlights Revenue for the quarter totaled $261 million an increase of 13% compared to $232 million during the same period of the prior … RCT presented robust high-quality data and clinical studies of Impella heart pumps at Transcatheter Cardiovascular …
Type: Press Release
… revenue of approximately $2006 million an increase of 30% compared to revenue of $1540 million for the same period of … also be available on the investor section of the companys website at wwwabiomedcom A replay of the webcast will be …
Type: Press Release
… SAN FRANCISCO--(BUSINESS WIRE)--Sep 26 2019-- Abiomed (NASDAQ ABMD) announces the results of … multimedia View the full release here https//wwwbusinesswirecom/news/home/20190926005305/en/ PROTECT III Presented at … Medical School The PROTECT series of FDA clinical studies which includes PROTECT I the PROTECT II RCT and PROTECT …
Type: Press Release
… DANVERS Mass Aug 26 2013 (GLOBE NEWSWIRE) -- Abiomed Inc (NasdaqABMD) a … and other federal agencies This contract allows the Company to make the Impella platform available through an … next generation cardiac support devices like Impella is becoming ubiquitous particularly for VA hospitals While we are …
Type: Press Release
… Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that … is a warning sign that a patient is at an increased risk of dying and should trigger a comprehensive evaluation for … who would not have qualified for the premarket clinical studies were more likely to have been in cardiogenic shock for …
Type: Press Release
… NEW ORLEANS – Johnson & Johnson (NYSE JNJ) – March 28 2026 – Randomized controlled trial (RCT) data presented at the … worldwide[1] Findings from the trial support future studies on whether pre-PCI treatment with Impella CP opens a … in patients with anterior STEMI without cardiogenic shock compared with PCI alone The hypertensive nature of most …